News Daily News Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients L.A. McKeown December 06, 2019
News Industry News FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy May 13, 2019